October 28, 2013
Christopher Amling, M.D. '85, FACS, chair and professor of urology and a leader in the OHSU Knight Cancer Institute, has been appointed the first John Barry Endowed Chair of Urology, effective July 1.
The endowed chair is named in honor of John Barry, M.D. R '73, professor of surgery and a pioneer in renal transplant, for his significant contributions to the field of urology. Dr. Barry is the immediate past chair of the Division (now Department) of Urology at OHSU.
Several gifts from OHSU faculty, staff, alumni and friends helped the OHSU Knight Cancer Institute reach its fundraising goal of $2.5 million to establish the endowed chair.
"Our entire family is inspired by the Department of Urology at OHSU and Dr. Amling's commitment to excellent care, innovative research and education," said Mark Goodman of the Doug and Lila Goodman family, one of the fund's top donors. "We chose to support the John Barry Chair for Urology because we want to see the great strides being made in urologic oncology continue and are thrilled to be a part of helping to build a program that is well on its way becoming one of the top ten in the country."
The appointment recognizes Dr. Amling as a faculty member who has achieved exceptional distinction. "Dr. Amling is an international authority on the use of innovative, minimally invasive treatments for urologic cancer, having published over 150 articles worldwide in leading journals in his field," said Jeanette Mladenovic, M.D., MBA, MACP, OHSU provost.
"The John Barry EndowedChair for Urology will support critical resources to advance research, education and clinical activities, while establishing OHSU as a program of excellence across the nation," said Dr. Amling.
About Dr. Amling
Dr. Amling specializes in treating cancers of the urinary and reproductive system, including the prostate, kidneys and bladder. He is an expert in minimally invasive cancer treatments, including robotic surgery for prostate, bladder and kidney cancer.
Before coming to OHSU, Dr. Amling directed the Division of Urology at the University of Alabama at Birmingham, where he held the Anton J. Beuschen Chair in urologic surgery and research. Previously, he was chairman of the Department of Urology at the U.S. Naval Medical Center in San Diego.
Dr. Amling is a national and international authority on the latest prostate cancer treatments, including surgery with the da Vinci robotic system. He has also developed new ways to educate surgical residents and published many articles in medical journals on diagnosing and treating prostate cancer.
Dr. Amling, an Oregon native, grew up in Coquille and graduated from the University of Oregon and OHSU School of Medicine. He is a fellow of the American College of Surgeons and a member of the American Urologic Association, which chose him for a prestigious award in 2009. Each year, the Gold Cystoscope Award goes to a single urologist who has made important contributions to the specialty within 13 years of finishing residency training.
Other awards and honors include being elected president of the Society of University Urologists, selection to the American Board of Urology Exam Committee and the Residency Review Committee for urology, and serving on the editorial board of the Journal of Urology. Dr. Amling was recently honored by selection to membership in the both the American Association of Genitourinary Surgeons (AAGUS) and the American Surgical Association (ASA). These top honors come from two of the oldest and most prestigious surgical organizations in the United States today.
About Dr. Barry
Dr. Barry has been a faculty member at OHSU since 1973. He was director of kidney transplantation from 1976 to 2009, head of the Division of Abdominal Organ Transplantation from 1990 to 1992, and head of the Division of Urology and Renal Transplantation from 1980 to 2008. He is currently part-time as professor of urology and surgery, Division of Abdominal Organ Transplantation.
He has been president of the following organizations: the American Urological Association, the American Board of Urology, the Western Section of the American Urological Association, the Northwest Urological Society, the Oregon Urological Society, the Urologic Society of Transplantation and Vascular Surgery, the Western Association of Transplant Surgeons, and the Pacific Northwest Transplant Society. He has been a member of the Board of Directors of the United Network for Organ Sharing.
He has been labeled as "One of the Best Doctors in America" by Woodward/White, as "One of our Best Doctors" in Portland Magazine, "One of the Best 400 Physicians in America" by Good Housekeeping Magazine, and as "One of the Best Medical Specialists in the USA" by Town and Country Magazine. He received the Medical Research Foundation of Oregon Discovery Award in 1994, the Distinguished Faculty Award from OHSU in 2002, and the American Urological Association's Certificate of Achievement Award in 2003, the Distinguished Alumnus Award from the OHSU Department of Surgery in 2011, and Honorary Membership in the American Urological Association in 2011. He has more than 300 publications in the fields of urology and renal transplantation, and he has been a visiting professor or guest speaker nationally and internationally.
His specialty areas are kidney transplantation, surgical diseases of the kidney, erectile dysfunction, Peyronie's disease, and reconstructive urology.
"I'm pleased that Dr. Amling is the first John Barry Chair of Urology," he said.
Faculty and Endowed Professorships
As called for in OHSU's Vision 2020 Strategic Plan and reinforced in the School of Medicine Research Roadmap, OHSU will partner to make Oregon a leader in health and science innovation to improve the health and well-being of Oregon and beyond. Key to achieving this goal is recruiting, supporting and retaining a faculty that will collaborate to drive excellence and innovation across OHSU.
A foundational element of OHSU's commitment to our faculty is to broaden and diversify funding sources through expanded and novel partnerships. OHSU's partnership with the OHSU Foundation includes a specific charge to diversify and deepen faculty support.
Endowed professorships are one such philanthropic tool. Currently, OHSU has 84 endowed professorships. Faculty members holding these positions cross all missions.
Endowed professorships allow world-class physicians and scientists to pursue promising work at OHSU that will hasten the pace of discovery and ultimately benefit patients across Oregon and far beyond. Income from professorship endowments typically provides salary support, start-up funds and other resources to enable the holder's maximum potential and productivity.